Abstract
Tissue factor pathway inhibitor (TFPI), a kunitztype inhibitor of the extrinsic coagulation pathway, factor VII coagulant (FVIIc), FVIIa, and the fibrinolytic factors plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (TPA) have been studied in various hyperlipidemias. Compared with a normal lipidic group, mean TFPI activity was 70% higher (P
Author supplied keywords
Cite
CITATION STYLE
Zitoun, D., Bara, L., Basdevant, A., & Samama, M. M. (1996). Levels of Factor VIIc Associated with Decreased Tissue Factor Pathway Inhibitor and Increased Plasminogen Activator Inhibitor-1 in Dyslipidemias. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(1), 77–81. https://doi.org/10.1161/01.ATV.16.1.77
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
